Stem Point Capital LP Immunocore Holdings PLC Transaction History
Stem Point Capital LP
- $340 Billion
- Q2 2024
A detailed history of Stem Point Capital LP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Stem Point Capital LP holds 339,351 shares of IMCR stock, worth $11.4 Million. This represents 3.38% of its overall portfolio holdings.
Number of Shares
339,351Holding current value
$11.4 Million% of portfolio
3.38%Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
150Shares Held
39.8MCall Options Held
157KPut Options Held
135K-
Wellington Management Group LLP Boston, MA6.38MShares$214 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$163 Million2.76% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.99MShares$100 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$95 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA1.95MShares$65.5 Million0.05% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.47B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...